Skip to main content
. 2015 Dec 21;11(2):1567–1573. doi: 10.3892/ol.2015.4043

Figure 5.

Figure 5.

3-BrPA has a greater inhibitory effect in ErbB2-overexpressing breast cancer cells than control cells in nude mice. Pre-established 231V or 231ErbB2 tumor xenografts were treated with control (phosphate-buffered saline), 3-BrPA (10 mg/kg, twice/week for 3 weeks). Data are presented as the mean ± standard error of the mean of three independent experiments. *P<0.05, 231 ErbB2 PBS group vs. 231 ErbB2 3-BrPA group; #P<0.05, 231 V 3-BrPA group vs. 231 ErbB2 3-BrPA group.